Stock Chart
MCRB
Type: SELL wallstreet
Strike: $20
Premium: $4.70
Expiry: Jan 15, 2027
Target: $21
Score: -79
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MCRB - Seres Therapeutics, Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of …
Key Statistics
More MCRB Analysis
This MCRB stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MCRB's price movements with trendlines, gamma walls, and key support/resistance levels.